A. Charlene Banard's most recent trade in Applied Molecular Transport Inc was a trade of 60,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 27, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Applied Molecular Transpor... | Charlene A. Banard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2023 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Molecular Transpor... | A. Banard Charlene | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2023 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Molecular Transpor... | A. Charlene Banard | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2023 | 20,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Applied Molecular Transpor... | Charlene A. Banard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Charlene A. Banard | EVP, Chief Technical Officer | Sale of securities on an exchange or to another person at price $ 2.04 per share. | 16 May 2023 | 19,040 | 276,010 (0%) | 0% | 2.0 | 38,784 | Common Stock |
| Atara Biotherapeutics Inc | Charlene A. Banard | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 314,325 | 314,325 | - | - | Employee Stock Option (Right to Buy) | |
| Atara Biotherapeutics Inc | Charlene A. Banard | EVP, Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 139,700 | 295,050 (0%) | 0% | 0 | Common Stock | |
| Applied Molecular Transpor... | Charlene A. Banard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Applied Molecular Transpor... | Charlene A. Banard | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 60,000 | 60,000 | - | - | Right to Buy (Stock Option) |